Page last updated: 2024-10-25

deferoxamine and Synovitis

deferoxamine has been researched along with Synovitis in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Synovitis: Inflammation of the SYNOVIAL MEMBRANE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blake, DR1
Hall, ND1
Bacon, PA2
Dieppe, PA1
Halliwell, B1
Gutteridge, JM1
Allan, IM1
Lunec, J1
Salmon, M1

Other Studies

2 other studies available for deferoxamine and Synovitis

ArticleYear
Effect of a specific iron chelating agent on animal models of inflammation.
    Annals of the rheumatic diseases, 1983, Volume: 42, Issue:1

    Topics: Acute Disease; Animals; Brain; Catalysis; Chronic Disease; Deferoxamine; Disease Models, Animal; Fem

1983
Reactive oxygen species selectively deplete normal T lymphocytes via a hydroxyl radical dependent mechanism.
    Scandinavian journal of immunology, 1987, Volume: 26, Issue:1

    Topics: Adult; Antioxidants; Cell Survival; Deferoxamine; Dose-Response Relationship, Radiation; Humans; Hyd

1987